This is notable since lack of N-linked glycosylation of IGF-1R was previously found to impair the membrane localization of IGF-1R and led to anti-IGF-1R antibody (figitumumab) insensitivity in gastric and hepatocellular cancer cell lines47. Here, IGF1R is linked to hepatocellular carcinoma.